PCM
DXCM icon

Prelude Capital Management’s DexCom DXCM Stock Holding History

Prelude Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-400
Closed -$15K – 1988
2019
Q3 		$15K Hold
400
– – ﹤0.01% 1433
2019
Q2 		$15K Buy
+400
New +$12.6K ﹤0.01% 1330

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Prelude Capital Management's DXCM Position: Q2 2026 in Review

Prelude Capital Management reduced its DexCom (DXCM) stake by 30% in Q2 2026, selling an estimated $112K and leaving 3,857 shares worth $260K. The position accounts for 0.02% of the portfolio, ranked #850.

Prelude Capital Management first reported a position in DXCM in Q4 2014 and has held it in 26 quarters since. The position peaked at $2.71M in Q1 2022. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Prelude Capital Management held 3,857 shares of DexCom worth $260K as of Q2 2026.
  • Prelude Capital Management sold 1,686 DexCom shares in Q2 2026, an estimated $112K.
  • DexCom made up 0.02% of Prelude Capital Management's portfolio in Q2 2026, its #850 holding.
  • Prelude Capital Management first reported a position in DexCom in Q4 2014 and has held it in 26 quarters since.
  • Prelude Capital Management's DexCom position peaked at $2.71M in Q1 2022.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.